Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Young Han C, Bedia JS, Yang WL, Hawley SJ, Bergan L, Hopper M, Celestino J, Guo J, Gornet TG, Soosaipillai A, Yang H, Doskocil SD, Lokshin AE, Handy BC, Diamandis EP, Moore RG, Lu KH, Lu Z, Anderson KS, Drescher CW, Skates SJ, Bast RC Jr. Young Han C, et al. Among authors: anderson ks. Br J Cancer. 2024 Mar;130(5):861-868. doi: 10.1038/s41416-023-02560-z. Epub 2024 Jan 9. Br J Cancer. 2024. PMID: 38195887 Free PMC article.
Autoantibody signature for the serologic detection of ovarian cancer.
Anderson KS, Cramer DW, Sibani S, Wallstrom G, Wong J, Park J, Qiu J, Vitonis A, LaBaer J. Anderson KS, et al. J Proteome Res. 2015 Jan 2;14(1):578-86. doi: 10.1021/pr500908n. Epub 2014 Nov 17. J Proteome Res. 2015. PMID: 25365139 Free PMC article.
Autoantibody biomarkers for the detection of serous ovarian cancer.
Katchman BA, Chowell D, Wallstrom G, Vitonis AF, LaBaer J, Cramer DW, Anderson KS. Katchman BA, et al. Among authors: anderson ks. Gynecol Oncol. 2017 Jul;146(1):129-136. doi: 10.1016/j.ygyno.2017.04.005. Epub 2017 Apr 18. Gynecol Oncol. 2017. PMID: 28427776 Free PMC article.
Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation.
Kaaks R, Fortner RT, Hüsing A, Barrdahl M, Hopper M, Johnson T, Tjønneland A, Hansen L, Overvad K, Fournier A, Boutron-Ruault MC, Kvaskoff M, Dossus L, Johansson M, Boeing H, Trichopoulou A, Benetou V, La Vecchia C, Sieri S, Mattiello A, Palli D, Tumino R, Matullo G, Onland-Moret NC, Gram IT, Weiderpass E, Sánchez MJ, Navarro Sanchez C, Duell EJ, Ardanaz E, Larranaga N, Lundin E, Idahl A, Jirström K, Nodin B, Travis RC, Riboli E, Merritt M, Aune D, Terry K, Cramer DW, Anderson KS. Kaaks R, et al. Among authors: anderson ks. Int J Cancer. 2018 Aug 1;143(3):515-526. doi: 10.1002/ijc.31335. Epub 2018 Mar 8. Int J Cancer. 2018. PMID: 29473162 Free PMC article.
Autoantibodies in Early Detection of Breast Cancer.
Rauf F, Anderson KS, LaBaer J. Rauf F, et al. Among authors: anderson ks. Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2475-2485. doi: 10.1158/1055-9965.EPI-20-0331. Epub 2020 Sep 29. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32994341 Free PMC article.
Biomarkers and Strategies for Early Detection of Ovarian Cancer.
Bast RC Jr, Lu Z, Han CY, Lu KH, Anderson KS, Drescher CW, Skates SJ. Bast RC Jr, et al. Among authors: anderson ks. Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2504-2512. doi: 10.1158/1055-9965.EPI-20-1057. Epub 2020 Oct 13. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 33051337 Free PMC article.
The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II-III and metastatic breast cancers.
Anderson KS, Erick TK, Chen M, Daley H, Campbell M, Colson Y, Mihm M, Zakka LR, Hopper M, Barry W, Winer EP, Dranoff G, Overmoyer B. Anderson KS, et al. Breast Cancer Res Treat. 2022 Jul;194(1):65-78. doi: 10.1007/s10549-022-06562-y. Epub 2022 Apr 28. Breast Cancer Res Treat. 2022. PMID: 35482127 Free PMC article. Clinical Trial.
360 results